The North America controlled substance market is witnessing steady growth, supported by demand for regulated pharmaceutical therapies and increasing emphasis on safe prescribing, distribution, and monitoring. Strong regulatory frameworks, expanding healthcare infrastructure, and the adoption of digital prescription and tracking technologies are contributing to market development. Continued...